Degenerated conjunctival and corneal epithelial cells

Degenerated and dead conjunctival and corneal epithelial cells refer to non-viable epithelial cells on the ocular surface, resulting from injury, inflammation, infection, or chronic conditions like dry eye disease, rather than a specific molecular entity or receptor[1][2][3]. Healthy conjunctival epithelium is a non-keratinized stratified squamous or columnar layer (3-5 cells thick) with goblet cells secreting mucins for tear film stability, while corneal epithelium (5-7 cells thick) maintains transparency and barrier function; degeneration disrupts this, leading to exposure, ulceration, and vision impairment[1][2][3]. These cells are sloughed off naturally or pathologically, with stem cells in limbal (for cornea) and forniceal/bulbar (for conjunctiva) regions driving regeneration via proliferation and centripetal migration[3]. In disease, their loss manifests as epithelial defects visible via fluorescein staining, associating with conditions like limbal stem cell deficiency or Stevens-Johnson syndrome[3]. This is not a therapeutic target like a receptor or enzyme but a pathological state treated indirectly by promoting re-epithelialization with lubricants, anti-inflammatories (e.g., cyclosporine), or autologous serum to support healing without direct drug interactions[1][2]. No specific drugs target these dead cells; therapies aim to prevent further loss and stimulate viable cell turnover[1][2][3].

Other names

Dead conjunctival epithelial cellsDegenerated corneal epithelial cellsDamaged ocular surface epithelial cells